Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2029 125

  1. Study completion Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06882772

  2. Study completion Optimizing Reperfusion to Improve Outcomes and Neurologic Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06990867

  3. Primary completion Metabolic Surgery for Atrial Fibrillation Elimination Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07027969

  4. Study completion A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07146048

  5. Study completion Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07347626

  6. Primary completion Retrograde Ascending Dissection: Intraluminal Aortic Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405242

  7. Primary completion Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07548281

  8. Primary completion OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07576257

  9. Study completion CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07612774

  10. Study completion In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07622485

  11. Study completion STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07644247

  12. Primary completion Comparison of Tunneled Cuffed Dialysis Catheters Versus Arteriovenous Fistulae in Elderly or Multimorbid Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07649083

  13. Study completion Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07678021

  14. Primary completion Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07678021

  15. Primary completion Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07746271

  16. Study completion Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762755

  17. Study completion The Variation in Electrode Configuration for Termination of Out-of-Hospital Rhythms That Are Shockable in Cardiac Arrest Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07818785

  18. Study completion Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07827521

  19. Study completion Percutaneous Stellate Ganglion Block as First Line Treatment in Patients With Electrical Storm: the STAR 2 Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07841080

  20. Primary completion Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07852637

  21. Study completion Adenosine A2a Receptor-Mediated Neuroinflammation in Remote Ischemic Conditioning for Post-Stroke Sleep Disorders Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07874594

  22. Study completion Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07902791

  23. Study completion Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07917078

  24. Primary completion Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07928505

January 2030 35

  1. Primary completion Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03206060

  2. Study completion Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05015660

  3. Study completion Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05494034

  4. Study completion Beta-blockade in Unruptured Intracranial Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06249802

  5. Primary completion Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06440707

  6. Primary completion Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07257198

  7. Study completion Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07575269

  8. Study completion Impact of Non-invasive Brain Stimulation on Motor Recuperation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01544699

  9. Study completion Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03728985

  10. Primary completion Effect of Visual Retraining After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06121219

  11. Study completion Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06693011

  12. Study completion HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07123779

  13. Study completion Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07374042

  14. Primary completion Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07374042

  15. Study completion Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07507500

  16. Study completion BHB-1893 vs. Placebo for Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07946107

  17. Study completion An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07517263

  18. Primary completion An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07517263

  19. Study completion Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05952206

  20. Study completion Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05115214

  21. Study completion Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05144503

  22. Primary completion Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07388030

  23. Primary completion REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07410117

  24. Study completion A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07900438

  25. Study completion Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05473520

  26. Primary completion Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05473520

  27. Study completion Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05696444

  28. Study completion StrokeNet Thrombectomy Endovascular Platform Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06289985

  29. Study completion Assessing the Safety and Efficacy of the LAmbre™ Plus Device Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06465706

  30. Study completion Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06767774

  31. Study completion Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07589387

  32. Primary completion Naloxone for In-Hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07806565

  33. Study completion Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07870681

February 2030 19

  1. Study completion Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06468202

  2. Study completion US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04852783

  3. Study completion PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05195905

  4. Primary completion PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05195905

  5. Study completion Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06785974

  6. Primary completion Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07225075

  7. Study completion AMPLATZER PFO Occluder Post Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03309332

  8. Primary completion AMPLATZER PFO Occluder Post Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03309332

  9. Study completion Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07384143

  10. Primary completion Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07384143

  11. Study completion DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05305482

  12. Primary completion DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05305482

  13. Study completion Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07414225

  14. Primary completion Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07414225

  15. Study completion Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07539259

  16. Study completion Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762547

  17. Primary completion Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762547

  18. Study completion APEX-STROKE Adaptive Platform Trial for Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07784569

  19. Study completion APEX-STROKE EAGLE Domain (EAGLE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07790354

March 2030 31

  1. Primary completion A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04671771

  2. Study completion Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07766668

  3. Study completion NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07806149

  4. Study completion Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Endovascular Therapy in Anterior Circulation Large Vessel Occlusion Stroke Within 4.5-24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07912970

  5. Study completion Individualized Genotype-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07939516

  6. Study completion Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02050113

  7. Primary completion Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02050113

  8. Primary completion Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05347069

  9. Primary completion Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05569772

  10. Primary completion Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06279793

  11. Primary completion Vitamin D and Type 2 Diabetes - Treat-To-Target Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07448974

  12. Primary completion Selenium Intervention Registry Randomized Trial in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07543562

  13. Primary completion Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07586540

  14. Study completion A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668336

  15. Primary completion A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668336

  16. Primary completion Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07688551

  17. Study completion A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07839936

  18. Primary completion Very-Low-Field MRI for the Diagnosis of Acute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07930013

  19. Study completion A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05646381

  20. Primary completion A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05646381

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Calcium-Phosphorus Regulation Therapy on Heart Valve Disease Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06660524

  2. Primary completion Use of App for Stroke Assessment VS Standard Level of Care During Prehospital Stroke Assessment Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06672757

  3. Study completion A Prospective, Multi-center Registry to Evaluate Safety and Efficacy of Hativ® ELectrocardiogram Monitoring on Patients with Hemodialysis Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06688565

  4. Study start The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06700239

  5. Study completion Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06703788

  6. Study completion Impact of Enhanced Information on Subjective Information Level and PROMs in Patients with Aortic Stenosis Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06706635

  7. Study completion Vaccination Against Influenza Pre-discharge in Heart Failure Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06725927

  8. Study completion Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06728605

  9. Primary completion Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06728605

  10. Study start Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06728605

  11. Study completion Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI) Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06754839

  12. Primary completion Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06760078

  13. Primary completion Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06782646

  14. Study start A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06789302

  15. Study completion Silymarin's Advantage on Graft Effectiveness Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06801886

  16. Primary completion Silymarin's Advantage on Graft Effectiveness Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06801886

  17. Study completion Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06825182

  18. Study completion Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06852079

  19. Primary completion Transcutaneous Laser Therapy in Chronic Kidney Disease Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06855992

  20. Study completion Study on the Trans-Carotid Artery Occlusion Shunt System Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06924593

  21. Primary completion Study on the Trans-Carotid Artery Occlusion Shunt System Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06924593

  22. Primary completion Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06946732

  23. Study completion High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07059689

  24. Primary completion High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07059689

  25. Study start A Study to Evaluate the Safety and Effectiveness of the FastWave Artero™ Peripheral Intravascular Lithotripsy (IVL) System in Adults With Peripheral Artery Disease (PAD) Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07209085

  26. Study start CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA) Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220304

  27. Study start Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07238972

  28. Study start Evaluation of a Single-lead ECG Patch-based Telemetry System for In-hospital Monitoring Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07260721

  29. Study start Finerenone and Cardiac Remodeling Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07270367

  30. Study completion A Study on the Effect of CGM Alone on Glycemic Metrics in Type 2 Diabetes Patients Not Using Insulin, Without Additional Interventions Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07298850

  31. Study start Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07308184

  32. Primary completion Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03642509

  33. Primary completion The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03840226

  34. Study completion Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS) Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04707261

  35. Primary completion Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04814212

  36. Study completion IABP In AMI Patients With SCAI-B Study Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04989777

  37. Primary completion IABP In AMI Patients With SCAI-B Study Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04989777

  38. Primary completion Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Upper Extremity Motor Function in Stroke Patients Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05646134

  39. Study completion Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation. Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05720572

  40. Study completion Comparison of Expandable and Fixed Size Cryoballoon for the Treatment of Paroxysmal Atrial Fibrillation Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06183879

  41. Primary completion Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06711302

  42. Study completion Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06765265

  43. Primary completion Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06765265

  44. Study start Hebbian-Type Associative Stimulation in Stroke Rehabilitation Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07085910

  45. Primary completion Effect of Digital Intervention on Self-management of Hypertensive Patients at High Risk of Stroke Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07089810

  46. Study start Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07223892

  47. Study start Dronedarone Rhythm Intervention for Early Atrial Fibrillation Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07270848

  48. Study start CGUARDIANS III IDE Pivotal Trial Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07277296

  49. Study start Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07279987

  50. Study start Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction. Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07288749

  51. Study start Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07290699

  52. Study start Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes Registry record

    Expected 2026-01-01; that period ended on 2026-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07335185

  53. Primary completion Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions Registry record

    Expected 2026-01-02; that period ended on 2026-01-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05894863

  54. Study completion Transcatheter Aortic Valve Implantation Registry at the National Research Center for Cardiac Surgery, Nur-Sultan, Kazakhstan Registry record

    Expected 2026-01-10; that period ended on 2026-01-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06874465

  55. Study start Effects and Feasibility of Photobiomodulation at 830nm Nanometers in the Treatment of Diabetic Ulcers Registry record

    Expected 2026-01-10; that period ended on 2026-01-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07043868

  56. Study completion Effect of Digital Intervention on Self-management of Hypertensive Patients at High Risk of Stroke Registry record

    Expected 2026-01-10; that period ended on 2026-01-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07089810

  57. Study start Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion Registry record

    Expected 2026-01-12; that period ended on 2026-01-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07335107

  58. Study start Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management Registry record

    Expected 2026-01-15; that period ended on 2026-01-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07279259

  59. Study start Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms Registry record

    Expected 2026-01-20; that period ended on 2026-01-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07372612

  60. Primary completion Preventing Hypoxia in Sedated TAVI: SuperNO₂VA vs. Conventional Oxygen Registry record

    Expected 2026-01-25; that period ended on 2026-01-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07006064

  61. Study completion Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT) Registry record

    Expected 2026-01-29; that period ended on 2026-01-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04328181

  62. Primary completion Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT) Registry record

    Expected 2026-01-29; that period ended on 2026-01-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04328181

  63. Study start Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke Registry record

    Expected 2026-01-30; that period ended on 2026-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07365475

  64. Study completion The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03936647

  65. Study completion MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03961334

  66. Study completion Project My Heart Your Heart: Pacemaker Reuse Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04016870

  67. Primary completion Project My Heart Your Heart: Pacemaker Reuse Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04016870

  68. Study completion CRT-P or CRT-D in Dilated Cardiomyopathy Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04139460

  69. Primary completion CRT-P or CRT-D in Dilated Cardiomyopathy Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04139460

  70. Study completion Metformin for Abdominal Aortic Aneurysm Growth Inhibition Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04224051

  71. Primary completion Metformin for Abdominal Aortic Aneurysm Growth Inhibition Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04224051

  72. Study completion Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04419779

  73. Primary completion Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04419779

  74. Primary completion Long-term Beta-blocker Therapy After Acute Myocardial Infarction Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04769362

  75. Study completion D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04784039

  76. Primary completion D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04784039

  77. Study completion The COlchicine HypERtENsion Trial Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04916522

  78. Primary completion The COlchicine HypERtENsion Trial Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04916522

  79. Study completion AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05649904

  80. Primary completion AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05649904

  81. Primary completion Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05670028

  82. Study completion RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05883631

  83. Primary completion RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05883631

  84. Study completion A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05961787

  85. Primary completion IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05971394

  86. Study completion Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06060483

  87. Primary completion SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06442280

  88. Study completion StatSeal vs Figure-of-Eight Suture for Vascular Closure in AF Ablation Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06627959

  89. Study completion Aleeto in Acute ISchemic Stroke:A RandomISed Controlled Clinical Trial Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06759753

  90. Study completion Transcutaneous Laser Therapy in Chronic Kidney Disease Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06855992

  91. Primary completion A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07109700

  92. Primary completion The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07167550

  93. Primary completion FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07174206

  94. Study start Antihypertensive Drug Selection Based on Hemodynamic Phenotypes Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07240909

  95. Study start Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin. Registry record

    Expected 2026-01-31; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07308925

  96. Study start Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07314775

  97. Study start Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx) Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07332871

  98. Study start Efficacy and Safety of Compression Boots in Patients With Acute Decompensated Heart Failure. Registry record

    Expected 2026-01; that period ended on 2026-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07377019

  99. Primary completion Oral Bedtime Melatonin in Critically Ill Patients Registry record

    Expected 2026-02-01; that period ended on 2026-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06156059

  100. Primary completion DCB vs. DES in Bifurcation Coronary Lesions Registry record

    Expected 2026-02-01; that period ended on 2026-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06551662